Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2024 to 31 January 2024 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council)

eu member state veterinary medicinal product marketing standard market approval drug surveillance withdrawal from the market medicinal product

Authors

Citation: Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 January 2024 to 31 January 2024 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council or Article 5 of Regulation (EU) 2019/6 of the European Parliament and of the Council) (OJ C, C/2024/1495, 29.02.2024, ELI: http://data.europa.eu/eli/C/2024/1495/oj )